Trial Outcomes & Findings for A Behavioral Intervention To Improve Hypertension Control In Veterans (NCT NCT00286754)
NCT ID: NCT00286754
Last Updated: 2015-06-01
Results Overview
Blood pressure Control at 6 months
COMPLETED
NA
533 participants
6 months
2015-06-01
Participant Flow
Participant milestones
| Measure |
Stage-matched Intervention (SM)
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
|
Health Education Intervention (HEI)
6 monthly phone calls of non-tailored counseling for diet, medication and exercise
|
Usual Care (UC)
treatment as usual with no additional counseling
|
|---|---|---|---|
|
Overall Study
STARTED
|
176
|
177
|
180
|
|
Overall Study
COMPLETED
|
156
|
159
|
170
|
|
Overall Study
NOT COMPLETED
|
20
|
18
|
10
|
Reasons for withdrawal
| Measure |
Stage-matched Intervention (SM)
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
|
Health Education Intervention (HEI)
6 monthly phone calls of non-tailored counseling for diet, medication and exercise
|
Usual Care (UC)
treatment as usual with no additional counseling
|
|---|---|---|---|
|
Overall Study
Adverse Event
|
2
|
2
|
3
|
|
Overall Study
Withdrawal by Subject
|
6
|
2
|
0
|
|
Overall Study
Lost to Follow-up
|
12
|
14
|
6
|
|
Overall Study
Moved out of state
|
0
|
0
|
1
|
Baseline Characteristics
A Behavioral Intervention To Improve Hypertension Control In Veterans
Baseline characteristics by cohort
| Measure |
Stage-Matched Intervention (SMI)
n=176 Participants
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
|
Health Education Intervention (HEI)
n=177 Participants
6 monthly calls of nontailored counseling for diet, medication and exercise
|
Usual Care (UC)
n=180 Participants
treatment as usual for hypertension
|
Total
n=533 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
History of revascularization
History of revascularization
|
27 participants
n=99 Participants
|
28 participants
n=107 Participants
|
31 participants
n=206 Participants
|
86 participants
n=157 Participants
|
|
History of revascularization
No history of revascularization
|
149 participants
n=99 Participants
|
149 participants
n=107 Participants
|
149 participants
n=206 Participants
|
447 participants
n=157 Participants
|
|
Hyperlipidemia
Hyperlipidemia
|
39 participants
n=99 Participants
|
38 participants
n=107 Participants
|
52 participants
n=206 Participants
|
129 participants
n=157 Participants
|
|
Age, Continuous
Age and Standard Deviation
|
66.4 years
STANDARD_DEVIATION 8.8 • n=99 Participants
|
66.5 years
STANDARD_DEVIATION 12.8 • n=107 Participants
|
65.4 years
STANDARD_DEVIATION 10.2 • n=206 Participants
|
66.1 years
STANDARD_DEVIATION 18.5 • n=157 Participants
|
|
Sex: Female, Male
Female
|
2 Participants
n=99 Participants
|
1 Participants
n=107 Participants
|
4 Participants
n=206 Participants
|
7 Participants
n=157 Participants
|
|
Sex: Female, Male
Male
|
174 Participants
n=99 Participants
|
176 Participants
n=107 Participants
|
176 Participants
n=206 Participants
|
526 Participants
n=157 Participants
|
|
Race/Ethnicity, Customized
White (non-Hispanic)
|
81 participants
n=99 Participants
|
60 participants
n=107 Participants
|
71 participants
n=206 Participants
|
212 participants
n=157 Participants
|
|
Race/Ethnicity, Customized
Black (non-Hispanic)
|
65 participants
n=99 Participants
|
77 participants
n=107 Participants
|
70 participants
n=206 Participants
|
212 participants
n=157 Participants
|
|
Race/Ethnicity, Customized
Hispanic
|
24 participants
n=99 Participants
|
29 participants
n=107 Participants
|
29 participants
n=206 Participants
|
82 participants
n=157 Participants
|
|
Race/Ethnicity, Customized
Other
|
6 participants
n=99 Participants
|
11 participants
n=107 Participants
|
10 participants
n=206 Participants
|
27 participants
n=157 Participants
|
|
Marital status
Married
|
59 participants
n=99 Participants
|
67 participants
n=107 Participants
|
70 participants
n=206 Participants
|
196 participants
n=157 Participants
|
|
Hyperlipidemia
No hyperlipidemia
|
137 participants
n=99 Participants
|
139 participants
n=107 Participants
|
128 participants
n=206 Participants
|
404 participants
n=157 Participants
|
|
Marital status
Not Married
|
117 participants
n=99 Participants
|
110 participants
n=107 Participants
|
110 participants
n=206 Participants
|
337 participants
n=157 Participants
|
|
Education
High school graduate or below
|
72 participants
n=99 Participants
|
89 participants
n=107 Participants
|
87 participants
n=206 Participants
|
248 participants
n=157 Participants
|
|
Education
Some college or higher
|
104 participants
n=99 Participants
|
88 participants
n=107 Participants
|
93 participants
n=206 Participants
|
285 participants
n=157 Participants
|
|
Employment status
Employed
|
29 participants
n=99 Participants
|
41 participants
n=107 Participants
|
41 participants
n=206 Participants
|
111 participants
n=157 Participants
|
|
Employment status
Not employed
|
147 participants
n=99 Participants
|
136 participants
n=107 Participants
|
139 participants
n=206 Participants
|
422 participants
n=157 Participants
|
|
Campus
Manhattan campus
|
96 participants
n=99 Participants
|
96 participants
n=107 Participants
|
97 participants
n=206 Participants
|
289 participants
n=157 Participants
|
|
Campus
Brooklyn campus
|
80 participants
n=99 Participants
|
81 participants
n=107 Participants
|
83 participants
n=206 Participants
|
244 participants
n=157 Participants
|
|
Smoking
Current smoker
|
35 participants
n=99 Participants
|
32 participants
n=107 Participants
|
32 participants
n=206 Participants
|
99 participants
n=157 Participants
|
|
Smoking
Current non-smoker
|
141 participants
n=99 Participants
|
145 participants
n=107 Participants
|
148 participants
n=206 Participants
|
434 participants
n=157 Participants
|
|
Body mass index
|
30.5 kg/m^2
STANDARD_DEVIATION 5.2 • n=99 Participants
|
31.2 kg/m^2
STANDARD_DEVIATION 5.8 • n=107 Participants
|
30.0 kg/m^2
STANDARD_DEVIATION 4.8 • n=206 Participants
|
30.5 kg/m^2
STANDARD_DEVIATION 5.3 • n=157 Participants
|
|
Blood pressure control
BP controlled
|
75 participants
n=99 Participants
|
72 participants
n=107 Participants
|
80 participants
n=206 Participants
|
227 participants
n=157 Participants
|
|
Blood pressure control
BP not controlled
|
101 participants
n=99 Participants
|
105 participants
n=107 Participants
|
100 participants
n=206 Participants
|
306 participants
n=157 Participants
|
|
Diabetes Mellitus
Diabetes mellitus
|
71 participants
n=99 Participants
|
83 participants
n=107 Participants
|
81 participants
n=206 Participants
|
235 participants
n=157 Participants
|
|
Diabetes Mellitus
No diabetes mellitus
|
105 participants
n=99 Participants
|
94 participants
n=107 Participants
|
99 participants
n=206 Participants
|
298 participants
n=157 Participants
|
|
Ischemic Heart Disease (IHD)
History of IHD
|
23 participants
n=99 Participants
|
22 participants
n=107 Participants
|
23 participants
n=206 Participants
|
68 participants
n=157 Participants
|
|
Ischemic Heart Disease (IHD)
No history of IHD
|
153 participants
n=99 Participants
|
155 participants
n=107 Participants
|
157 participants
n=206 Participants
|
465 participants
n=157 Participants
|
|
Estimated glomerular filtration rate (EGFR)
|
79.9 mL/min/1.73m^2
STANDARD_DEVIATION 25.5 • n=99 Participants
|
83.2 mL/min/1.73m^2
STANDARD_DEVIATION 46.3 • n=107 Participants
|
80.6 mL/min/1.73m^2
STANDARD_DEVIATION 28.4 • n=206 Participants
|
81.3 mL/min/1.73m^2
STANDARD_DEVIATION 35.8 • n=157 Participants
|
|
Systolic Blood Pressure, mm Mg
|
136.0 mm Hg
STANDARD_DEVIATION 11.8 • n=99 Participants
|
137.2 mm Hg
STANDARD_DEVIATION 17.7 • n=107 Participants
|
137.0 mm Hg
STANDARD_DEVIATION 12.9 • n=206 Participants
|
136.7 mm Hg
STANDARD_DEVIATION 15.5 • n=157 Participants
|
|
Diastolic blood pressure
|
75.5 mm Hg
STANDARD_DEVIATION 9.3 • n=99 Participants
|
76.1 mm Hg
STANDARD_DEVIATION 11.6 • n=107 Participants
|
75.0 mm Hg
STANDARD_DEVIATION 11.1 • n=206 Participants
|
75.5 mm Hg
STANDARD_DEVIATION 11.6 • n=157 Participants
|
|
Aerobic exercise
|
5.3 hours per week
STANDARD_DEVIATION 8.1 • n=99 Participants
|
4.5 hours per week
STANDARD_DEVIATION 5.9 • n=107 Participants
|
5.0 hours per week
STANDARD_DEVIATION 6.7 • n=206 Participants
|
4.9 hours per week
STANDARD_DEVIATION 6.7 • n=157 Participants
|
|
Medication adherence by Morisky scale
|
3.4 units on a scale
STANDARD_DEVIATION 0.93 • n=99 Participants
|
3.2 units on a scale
STANDARD_DEVIATION 0.67 • n=107 Participants
|
3.3 units on a scale
STANDARD_DEVIATION 0.94 • n=206 Participants
|
3.3 units on a scale
STANDARD_DEVIATION 0.88 • n=157 Participants
|
|
Number of antihypertensive medications
|
2.7 medications
STANDARD_DEVIATION 1.5 • n=99 Participants
|
2.8 medications
STANDARD_DEVIATION 1.3 • n=107 Participants
|
2.7 medications
STANDARD_DEVIATION 1.3 • n=206 Participants
|
2.7 medications
STANDARD_DEVIATION 1.4 • n=157 Participants
|
|
Diet stage of change
Action or Maintenance
|
69 participants
n=99 Participants
|
67 participants
n=107 Participants
|
70 participants
n=206 Participants
|
206 participants
n=157 Participants
|
|
Diet stage of change
Precontemplation, Contemplation or Preparation
|
107 participants
n=99 Participants
|
110 participants
n=107 Participants
|
110 participants
n=206 Participants
|
327 participants
n=157 Participants
|
|
Exercise Stage of Change
Action or Maintenance
|
125 participants
n=99 Participants
|
110 participants
n=107 Participants
|
108 participants
n=206 Participants
|
343 participants
n=157 Participants
|
|
Exercise Stage of Change
Precontemplation, Contemplation, or Preparation
|
51 participants
n=99 Participants
|
67 participants
n=107 Participants
|
72 participants
n=206 Participants
|
190 participants
n=157 Participants
|
|
Medication Stage of Change
Action or Maintenance
|
164 participants
n=99 Participants
|
170 participants
n=107 Participants
|
166 participants
n=206 Participants
|
500 participants
n=157 Participants
|
|
Medication Stage of Change
Precontemplation, Contemplation or Preparation
|
12 participants
n=99 Participants
|
7 participants
n=107 Participants
|
14 participants
n=206 Participants
|
33 participants
n=157 Participants
|
PRIMARY outcome
Timeframe: 6 monthsBlood pressure Control at 6 months
Outcome measures
| Measure |
Stage-matched Intervention (SMI)
n=156 Participants
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
|
Health Education Intervention (HEI)
n=159 Participants
6 monthly calls of nontailored counseling for diet, medication and exercise
|
Usual Care (UC)
n=170 Participants
treatment as usual for hypertension
|
|---|---|---|---|
|
Blood Pressure Control
BP controlled
|
0.646 proportion of participants
|
0.543 proportion of participants
|
0.458 proportion of participants
|
|
Blood Pressure Control
BP not controlled
|
0.354 proportion of participants
|
0.457 proportion of participants
|
0.542 proportion of participants
|
PRIMARY outcome
Timeframe: 6 monthsMean systolic Blood Pressure
Outcome measures
| Measure |
Stage-matched Intervention (SMI)
n=156 Participants
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
|
Health Education Intervention (HEI)
n=159 Participants
6 monthly calls of nontailored counseling for diet, medication and exercise
|
Usual Care (UC)
n=170 Participants
treatment as usual for hypertension
|
|---|---|---|---|
|
Systolic Blood Pressure
|
131.2 mm Hg
Interval 129.1 to 133.3
|
131.8 mm Hg
Interval 129.9 to 133.7
|
134.7 mm Hg
Interval 132.7 to 136.7
|
SECONDARY outcome
Timeframe: 6 monthsOutcome measures
| Measure |
Stage-matched Intervention (SMI)
n=156 Participants
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
|
Health Education Intervention (HEI)
n=159 Participants
6 monthly calls of nontailored counseling for diet, medication and exercise
|
Usual Care (UC)
n=170 Participants
treatment as usual for hypertension
|
|---|---|---|---|
|
Change in Proportion With BP Under Control From Baseline to 6 Months
|
.197 Proportion of participants
|
.118 Proportion of participants
|
.019 Proportion of participants
|
SECONDARY outcome
Timeframe: Baseline and 6 monthsOutcome measures
| Measure |
Stage-matched Intervention (SMI)
n=156 Participants
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
|
Health Education Intervention (HEI)
n=159 Participants
6 monthly calls of nontailored counseling for diet, medication and exercise
|
Usual Care (UC)
n=170 Participants
treatment as usual for hypertension
|
|---|---|---|---|
|
Change in Systolic Blood Pressure From Baseline to 6 Months
|
-4.7 mm Hg
Interval -6.9 to -2.5
|
-5.4 mm Hg
Interval -8.5 to -2.3
|
-2.7 mm Hg
Interval -5.0 to -0.4
|
SECONDARY outcome
Timeframe: baseline and 6 monthsOutcome measures
| Measure |
Stage-matched Intervention (SMI)
n=156 Participants
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
|
Health Education Intervention (HEI)
n=159 Participants
6 monthly calls of nontailored counseling for diet, medication and exercise
|
Usual Care (UC)
n=170 Participants
treatment as usual for hypertension
|
|---|---|---|---|
|
Change in Number of Cardio Exercise Hours From Baseline to 6 Months
|
-0.29 hours
Interval -1.7 to 1.1
|
0.53 hours
Interval -0.6 to 1.7
|
-0.43 hours
Interval -1.4 to 0.6
|
SECONDARY outcome
Timeframe: baseline and 6 monthsMorkisy medication adherence self-report questionnaire, a 4-item questionnaire scored from 0-4. A score of 4 is considered most adherent, and scores of less than 4 are defined as nonadherent
Outcome measures
| Measure |
Stage-matched Intervention (SMI)
n=156 Participants
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
|
Health Education Intervention (HEI)
n=159 Participants
6 monthly calls of nontailored counseling for diet, medication and exercise
|
Usual Care (UC)
n=170 Participants
treatment as usual for hypertension
|
|---|---|---|---|
|
Change in Morisky Score From Baseline to 6 Months
|
0.25 units on a scale
Interval 0.1 to 0.4
|
0.25 units on a scale
Interval 0.1 to 0.4
|
0.14 units on a scale
Interval 0.0 to 0.3
|
SECONDARY outcome
Timeframe: 6 monthsThe stages of change were: precontemplation, or no plans to adhere in \<6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for \<6 months; and maintenance, or adherence for ≥ 6 months. Patients were considered adherent to diet if they reported eating the appropriate diet for hypertension (low in salt and fat with fruits, vegetables, and low-or non-fat dairy products) at least 6 days per week.
Outcome measures
| Measure |
Stage-matched Intervention (SMI)
n=156 Participants
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
|
Health Education Intervention (HEI)
n=159 Participants
6 monthly calls of nontailored counseling for diet, medication and exercise
|
Usual Care (UC)
n=170 Participants
treatment as usual for hypertension
|
|---|---|---|---|
|
Diet Stage of Change
Action or Maintenance
|
87 participants
|
73 participants
|
73 participants
|
|
Diet Stage of Change
Precontemplation, Contemplation or Preparation
|
69 participants
|
86 participants
|
97 participants
|
SECONDARY outcome
Timeframe: 6 monthsThe stages of change were: precontemplation, or no plans to adhere in \<6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for \<6 months; and maintenance, or adherence for ≥ 6 months. Exercise adherence was defined as self-reported aerobic exercise for at least 3 days per week for at least 20 minutes each time. We used the lower threshold for exercise adherence due to our patient population with multiple comorbidities, consistent with Federal guidelines for older adults with chronic conditions.
Outcome measures
| Measure |
Stage-matched Intervention (SMI)
n=156 Participants
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
|
Health Education Intervention (HEI)
n=159 Participants
6 monthly calls of nontailored counseling for diet, medication and exercise
|
Usual Care (UC)
n=170 Participants
treatment as usual for hypertension
|
|---|---|---|---|
|
Exercise Stage of Change
Action or Maintenance
|
128 participants
|
124 participants
|
126 participants
|
|
Exercise Stage of Change
Precontemplation, Contemplation or Preparation
|
28 participants
|
35 participants
|
44 participants
|
SECONDARY outcome
Timeframe: 6 monthsThe stages of change were: precontemplation, or no plans to adhere in \<6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for \<6 months; and maintenance, or adherence for ≥ 6 months. Medication adherence was defined as self-report of taking BP medications as prescribed for at least 6 days per week.
Outcome measures
| Measure |
Stage-matched Intervention (SMI)
n=156 Participants
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
|
Health Education Intervention (HEI)
n=159 Participants
6 monthly calls of nontailored counseling for diet, medication and exercise
|
Usual Care (UC)
n=170 Participants
treatment as usual for hypertension
|
|---|---|---|---|
|
Medication Stage of Change
Action or Maintenance
|
148 participants
|
156 participants
|
163 participants
|
|
Medication Stage of Change
Precontemplation, Contemplation or Preparation
|
8 participants
|
3 participants
|
7 participants
|
Adverse Events
Stage-matched Intervention (SMI)
Health Education Intervention (HEI)
Usual Care (UC)
Serious adverse events
| Measure |
Stage-matched Intervention (SMI)
n=176 participants at risk
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
|
Health Education Intervention (HEI)
n=177 participants at risk
6 monthly phone calls of nontailored counseling for diet, medication and exercise
|
Usual Care (UC)
n=180 participants at risk
treatment as usual for hypertension
|
|---|---|---|---|
|
Cardiac disorders
Heart attack
|
1.1%
2/176 • Number of events 2 • 1 year
|
0.00%
0/177 • 1 year
|
0.56%
1/180 • Number of events 1 • 1 year
|
|
Vascular disorders
Stroke
|
0.00%
0/176 • 1 year
|
0.00%
0/177 • 1 year
|
1.1%
2/180 • Number of events 2 • 1 year
|
|
General disorders
Death
|
0.57%
1/176 • Number of events 1 • 1 year
|
0.56%
1/177 • Number of events 1 • 1 year
|
0.00%
0/180 • 1 year
|
Other adverse events
| Measure |
Stage-matched Intervention (SMI)
n=176 participants at risk
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
|
Health Education Intervention (HEI)
n=177 participants at risk
6 monthly phone calls of nontailored counseling for diet, medication and exercise
|
Usual Care (UC)
n=180 participants at risk
treatment as usual for hypertension
|
|---|---|---|---|
|
Cardiac disorders
Angina
|
2.8%
5/176 • Number of events 5 • 1 year
|
1.7%
3/177 • Number of events 3 • 1 year
|
2.2%
4/180 • Number of events 4 • 1 year
|
|
Injury, poisoning and procedural complications
broken bones
|
2.8%
5/176 • Number of events 5 • 1 year
|
0.56%
1/177 • Number of events 1 • 1 year
|
0.56%
1/180 • Number of events 1 • 1 year
|
|
Musculoskeletal and connective tissue disorders
torn ligament
|
1.1%
2/176 • Number of events 2 • 1 year
|
0.00%
0/177 • 1 year
|
1.1%
2/180 • Number of events 2 • 1 year
|
|
Cardiac disorders
hypertensive emergency
|
0.00%
0/176 • 1 year
|
0.56%
1/177 • Number of events 1 • 1 year
|
1.1%
2/180 • Number of events 2 • 1 year
|
|
Surgical and medical procedures
Coronary artery bypass graft
|
1.1%
2/176 • Number of events 2 • 1 year
|
1.1%
2/177 • Number of events 2 • 1 year
|
0.00%
0/180 • 1 year
|
Additional Information
Sundar Natarajan, MD, Staff Physician
Department of Veterans Affairs
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place